RIPK3 and acute myeloid leukemia: Nevertheless, this study also indicates that a JMJD3-mediated activation of innate immunity, as marked by the induction of RIPK3-IL-1β axis in a NF-κB-independent manner within AML cells, is unfavorable for the maintenance of malignancy34.